Hualan Biological Engineering, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001JN8
CNY
14.54
0.12 (0.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,575.88
4,360.45
5,319.24
4,498.55
4,417.35
5,002.32
3,683.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,575.88
4,360.45
5,319.24
4,498.55
4,417.35
5,002.32
3,683.70
Raw Material Cost
2,063.62
1,796.05
1,732.36
1,655.49
1,497.00
1,473.17
1,383.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
347.15
275.30
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.79
13.44
13.46
30.64
22.06
5.41
7.08
Selling and Distribution Expenses
1,006.36
1,010.11
1,436.74
1,180.89
952.46
1,271.00
673.19
Other Expenses
28.50
26.83
-13.37
-4.77
20.10
18.77
12.03
Total Expenditure (Excl Depreciation)
3,365.80
3,087.87
3,395.96
3,094.59
2,672.52
2,937.24
2,184.46
Operating Profit (PBDIT) excl Other Income
1210.1000000000001
1272.6000000000001
1923.3000000000002
1404
1744.8
2065.1
1499.1999999999998
Other Income
124.52
166.35
245.79
225.97
111.12
124.32
136.88
Operating Profit (PBDIT)
1,535.61
1,617.34
2,329.99
1,736.90
1,903.69
2,308.38
1,732.36
Interest
10.79
13.44
13.46
30.64
22.06
5.41
7.08
Exceptional Items
15.17
32.94
60.54
36.11
26.86
25.96
32.40
Gross Profit (PBDT)
2,512.27
2,564.40
3,586.88
2,843.06
2,920.35
3,529.14
2,299.81
Depreciation
281.55
272.24
273.79
287.59
206.32
186.78
161.12
Profit Before Tax
1,258.44
1,364.60
2,103.29
1,454.77
1,702.18
2,142.15
1,596.56
Tax
173.36
183.14
315.96
180.76
234.13
303.21
231.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
940.40
1,087.85
1,481.58
1,076.27
1,298.90
1,613.11
1,283.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
940.40
1,087.85
1,481.58
1,076.27
1,298.90
1,613.11
1,283.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
59.59
67.62
280.11
171.34
155.22
231.06
95.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
999.99
1,155.47
1,761.68
1,247.60
1,454.12
1,844.16
1,378.88
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
0.0
Reserves
11,500.61
11,858.78
11,359.43
10,398.47
8,336.96
7,528.54
6,543.13
Earnings per share (EPS)
0.52
0.59
0.81
0.59
0.71
0.89
0.7
Diluted Earnings per share
0.52
0.59
0.81
0.59
0.71
0.89
0.7
Operating Profit Margin (Excl OI)
24.68%
27.03%
34.04%
27.19%
35.91%
39.93%
38.94%
Gross Profit Margin
33.65%
37.54%
44.69%
38.73%
43.2%
46.56%
47.72%
PAT Margin
20.55%
24.95%
27.85%
23.92%
29.4%
32.25%
34.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 4.94% vs -18.02% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -13.46% vs -34.41% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -2.75% vs -30.38% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -19.40% vs -0.74% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Hualan Biological Engineering, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
4,575.88
0
4,575.88
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,575.88
0
4,575.88
Raw Material Cost
2,063.62
0
2,063.62
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.79
0
10.79
Selling and Distribution Expenses
1,006.36
0
1,006.36
Other Expenses
28.50
0.00
28.50
Total Expenditure (Excl Depreciation)
3,365.80
0
3,365.80
Operating Profit (PBDIT) excl Other Income
1,210.08
0.00
1,210.08
Other Income
124.52
0
124.52
Operating Profit (PBDIT)
1,535.61
0
1,535.61
Interest
10.79
0
10.79
Exceptional Items
15.17
0
15.17
Gross Profit (PBDT)
2,512.27
0
2,512.27
Depreciation
281.55
0
281.55
Profit Before Tax
1,258.44
0
1,258.44
Tax
173.36
0
173.36
Provisions and contingencies
0
0
0.00
Profit After Tax
940.40
0
940.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
940.40
0
940.40
Share in Profit of Associates
0
0
0.00
Minority Interest
59.59
0
59.59
Other related items
0.00
0.00
0.00
Consolidated Net Profit
999.99
0
999.99
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,500.61
0
11,500.61
Earnings per share (EPS)
0.52
0
0.52
Diluted Earnings per share
0.52
0
0.52
Operating Profit Margin (Excl OI)
24.68%
0%
0.00
24.68%
Gross Profit Margin
33.65%
0%
0.00
33.65%
PAT Margin
20.55%
0%
0.00
20.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 457.59 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 4.94% vs -18.02% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 100.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -13.46% vs -34.41% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 141.11 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -2.75% vs -30.38% in Dec 2024

Annual - Interest
Interest 1.08 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -19.40% vs -0.74% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.68%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024